Next-Gen MS: Feed-forward PRO Data for MS Research
Stopped early
Conditions studied: Multiple Sclerosis (MS)
In brief
This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).
Key facts
- Study ID
- NCT04907305
- Run by
- EMD Serono Research & Development Institute, Inc.
- People needed
- 1594
- Starts
- 2021-11-02
- Expected to finish
- 2024-02-19
- Last updated by the study team
- 2024-06-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants willing and able to provide written informed consent
- Participants with clinical diagnosis of Multiple Sclerosis (MS)
You may not qualify if…
- None
Where it is running
- Alabama Neurology Associates — Birmingham, Alabama, United States
- Georgetown University — Washington D.C., District of Columbia, United States
- Atlanta Neuroscience Institute — Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- The Memorial Hospital, d.b.a Memorial Healthcare — Owosso, Michigan, United States
- Oklahoma Medical Research Foundation — Oklahoma City, Oklahoma, United States
- The University of Texas of Austin — Austin, Texas, United States
- The University of Texas Health Science Center — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.